Iacta Alea Est: The Inexorable Advance of Tofacitinib in the Treatment of Dermatomyositis-Associated Rapidly Progressive Interstitial Lung Disease. A Case Report

• Asıl Yazarlar: Walter Conca (Yazar), Ihab Weheba (Yazar), Mohei-Eldin Abouzied (Yazar), Abeer Abdelsayed (Yazar), Yousif Aleyouni (Yazar), Eid Al‐Mutairy (Yazar), Nasir Bakshi (Yazar), Mohammad Khalid (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Frontiers Media S.A., 2020-12-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Rapidly progressive interstitial lung disease is typically associated with clinically amyopathic dermatomyositis and the anti-melanoma differentiation associated gene 5 antibody, a condition with high mortality and resistance to classic immunosuppression. Recent reports have described the efficacy o...